Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) are currently poised at 49.07% from the open today and are hovering around at $2.40. More than 278,770 shares have traded hands versus an average trading volume of 44.12K. At the current PPS, the market capiralization stands at $18.94M. The stock prices of Aethlon Medical, Inc. (NASDAQ:AEMD) are currently trading at -73.60% below its 52 week high and 56.70% above its 52 week low.
Aethlon Medical, Inc. (NASDAQ:AEMD) has been in the buzz for the right reasons. Recently, Aethlon Medical, Inc. (NASDAQ:AEMD) announced today that Company Chairman and CEO, Jim Joyce will present at the 2017 BIO International Convention (BIO 2017) on June 21, 2017 at 11:15 AM Pacific Time. BIO 2107, which is being held at the San Diego Convention Center, attracts more than 16,000 biotechnology industry executives from 76 countries. Mr. Joyce will present virus capture data from a recently concluded FDA-approved feasibility study that was designed to assess the safety of the Aethlon Hemopurifier® in health-compromised individuals infected with a viral pathogen.
Aethlon Medical, Inc. (NASDAQ:AEMD) is all set to post its earnings on Jun 28/a. As per Zack’s analyst ratings, Aethlon Medical, Inc. (NASDAQ:AEMD) has an average brokerage rating of . On a scale of 1-5, a rating of 1 or 2 would show a buy, and a score of 4 or 5 would indicate a sell call. A rating of 3 would suggest a hold on the stock. The consensus price on (NASDAQ:AEMD) is $ with a high of $ and a low of $.
Let’s take a look at the technical analysis.
The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction. Longer term, the trend strength is Minimum.
The Exponential Moving Average is similar to a simple moving average however it utilizes a weighting cog that exponentially drops from the recent data point. The study of EMA compares the short term, intermediate term and long term EMAs. The respective EMAs tend to give bullish signals when hovering above trailing EMAs and below the latest price and vice versa. EMA alerts constitute crossovers i.e. the 5-day EMA crosses below/above the 20 day EMA and EMA convergences 5-day EMA comparable to 13 day EMA. The long term and short term EMA’s of 1.92 and 2.26 are lower than the current trading price suggesting a bullish pattern in both short term as well as long term.
The relative strength index (RSI) can be defined as a momentum oscillator that can compute measure the velocity and extent of stock price changes. Momentum is computed as the ratio of positive price variations to negative price changes. The RSI study compares the current Relative Strength Index against oversold (30), overbought (70) and neutral (50) conditions. Alerts will apprise you when shares recede from oversold/overbought marks or breakthrough neutral (50). The current RSI is 62.51 suggesting a bullish price action.
Though Aethlon Medical, Inc. (NASDAQ:AEMD) represents an exciting growth story open to numerous attractive markets, it would be remarkable to see how it does for long-term investors.